Search Results

There are 12348 results for: content related to: Melanoma response and resistance – taking it to the tumor bank

  1. You have free access to this content
    Society for Melanoma Research 2013 Congress

    Pigment Cell & Melanoma Research

    Volume 26, Issue 6, November 2013, Pages: 932–1019,

    Article first published online : 24 OCT 2013, DOI: 10.1111/pcmr.12166

  2. You have free access to this content
    Society for Melanoma Research 2012 Congress

    Pigment Cell & Melanoma Research

    Volume 25, Issue 6, November 2012, Pages: 836–903,

    Article first published online : 19 OCT 2012, DOI: 10.1111/pcmr.12023

  3. You have free access to this content
    2011 International Melanoma Congress

    Pigment Cell & Melanoma Research

    Volume 24, Issue 5, October 2011, Pages: 990–1075,

    Article first published online : 10 OCT 2011, DOI: 10.1111/j.1755-148X.2011.00909.x

  4. You have free access to this content
    Society for Melanoma Research 2014 Congress

    Pigment Cell & Melanoma Research

    Volume 27, Issue 6, November 2014, Pages: 1169–1241,

    Article first published online : 23 OCT 2014, DOI: 10.1111/pcmr.12317

  5. You have free access to this content
    Society for Melanoma Research 2015 Congress

    Pigment Cell & Melanoma Research

    Volume 28, Issue 6, November 2015, Pages: 753–826,

    Article first published online : 17 OCT 2015, DOI: 10.1111/pcmr.12419

  6. You have free access to this content
    Melanoma 2010 Congress

    Pigment Cell & Melanoma Research

    Volume 23, Issue 6, December 2010, Pages: 874–1004,

    Article first published online : 13 OCT 2010, DOI: 10.1111/j.1755-148X.2010.00767.x

  7. You have full text access to this OnlineOpen article
    Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases

    Pigment Cell & Melanoma Research

    Volume 29, Issue 1, January 2016, Pages: 92–100, Heike Seifert, Eishu Hirata, Martin Gore, Komel Khabra, Christina Messiou, James Larkin and Erik Sahai

    Article first published online : 3 NOV 2015, DOI: 10.1111/pcmr.12424

  8. You have full text access to this OnlineOpen article
    Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting

    Cancer Medicine

    Volume 4, Issue 8, August 2015, Pages: 1205–1213, Geoffrey T. Gibney, Geneviève Gauthier, Charles Ayas, Philip Galebach, Eric Q. Wu, Sarang Abhyankar, Carolina Reyes, Annie Guérin and Yeun Mi Yim

    Article first published online : 20 MAY 2015, DOI: 10.1002/cam4.475

  9. You have free access to this content
    Mechanisms of intrinsic and acquired resistance to kinase-targeted therapies

    Pigment Cell & Melanoma Research

    Volume 25, Issue 6, November 2012, Pages: 819–831, Shubha Bagrodia, Tod Smeal and Robert T. Abraham

    Article first published online : 14 SEP 2012, DOI: 10.1111/pcmr.12007

  10. Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors

    Cancer

    Volume 121, Issue 21, November 1, 2015, Pages: 3826–3835, Alexander M. Menzies, James S. Wilmott, Martin Drummond, Serigne Lo, Megan Lyle, Matthew M. K. Chan, John F. Thompson, Alex Guminski, Matteo S. Carlino, Richard A. Scolyer, Richard F. Kefford and Georgina V. Long

    Article first published online : 28 JUL 2015, DOI: 10.1002/cncr.29586

  11. Unmet needs in melanoma research

    Pigment Cell & Melanoma Research

    Volume 27, Issue 6, November 2014, Page: 1003, Andrew Aplin, Marcus Bosenberg, Marisol Soengas, Lidia Kos, Heinz Arnheiter and Robert Kelsh

    Article first published online : 23 OCT 2014, DOI: 10.1111/pcmr.12321

  12. Meeting report from the 10th International Congress of the Society for Melanoma Research, Philadelphia, PA, November 2013

    Pigment Cell & Melanoma Research

    Volume 27, Issue 4, July 2014, Pages: E1–E12, Adina Vultur, Michael O'Connell, Marie Webster, Jessie Villanueva, Dorothee Herlyn, Rajasekharan Somasundaram, Clemens Krepler, Raza Zaidi, Elizabeth Patton, Aleksander Sekulic, Goran Jonsson and Ashani T. Weeraratna

    Article first published online : 6 MAY 2014, DOI: 10.1111/pcmr.12240

  13. The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitors

    Pigment Cell & Melanoma Research

    Volume 28, Issue 4, July 2015, Pages: 417–430, Casey G. Langdon, Matthew A. Held, James T. Platt, Katrina Meeth, Pinar Iyidogan, Ramanaiah Mamillapalli, Andrew B. Koo, Michael Klein, Zongzhi Liu, Marcus W. Bosenberg and David F. Stern

    Article first published online : 6 MAY 2015, DOI: 10.1111/pcmr.12376

  14. You have free access to this content
    Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma

    IUBMB Life

    Volume 65, Issue 9, September 2013, Pages: 748–758, Ao-Xue Wang and Xiao-Yi Qi

    Article first published online : 29 JUL 2013, DOI: 10.1002/iub.1193

  15. Clinical trials in melanoma patients with brain metastases

    Pigment Cell & Melanoma Research

    Volume 28, Issue 6, November 2015, Pages: 741–743, Melinda L. Yushak, Veronica L. Chiang and Harriet M. Kluger

    Article first published online : 20 AUG 2015, DOI: 10.1111/pcmr.12401

  16. Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010

    Pigment Cell & Melanoma Research

    Volume 24, Issue 1, February 2011, Pages: e1–e15, P. Hersey, K. S. M. Smalley, A. Weeraratna, M. Bosenberg, X. D. Zhang, N. K. Haass, E. Paton, G. Mann and R. A. Scolyer

    Article first published online : 22 DEC 2010, DOI: 10.1111/j.1755-148X.2010.00811.x

    Corrected by:

    Erratum

    Vol. 24, Issue 5, 989, Article first published online: 10 OCT 2011

  17. You have free access to this content
    Meeting report from the 2011 international melanoma congress, Tampa, Florida

    Pigment Cell & Melanoma Research

    Volume 25, Issue 1, January 2012, Pages: E1–E11, Keiran S. M. Smalley, Andrew E. Aplin, Keith T. Flaherty, Christoph Hoeller, Anja K. Bosserhoff, Nikolas K. Haass, Marcus Bosenberg, Antoni Ribas, Raymond Barnhill, Ragini Kudchadkar and Jane L. Messina

    Article first published online : 9 DEC 2011, DOI: 10.1111/j.1755-148X.2011.00943.x

  18. Riluzole is a radio-sensitizing agent in an in vivo model of brain metastasis derived from GRM1 expressing human melanoma cells

    Pigment Cell & Melanoma Research

    Volume 28, Issue 1, January 2015, Pages: 105–109, Brian A. Wall, Lumeng J. Yu, Atif Khan, Bruce Haffty, James S. Goydos and Suzie Chen

    Article first published online : 28 NOV 2014, DOI: 10.1111/pcmr.12327

  19. You have full text access to this OnlineOpen article
    Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery

    Cancer Medicine

    Volume 4, Issue 1, January 2015, Pages: 1–6, Karim Tazi, Amanda Hathaway, Cody Chiuzan and Keisuke Shirai

    Article first published online : 27 AUG 2014, DOI: 10.1002/cam4.315

  20. Paradoxical oncogenesis: are all BRAF inhibitors equal?

    Pigment Cell & Melanoma Research

    Volume 26, Issue 5, September 2013, Pages: 611–615, Alexander M. Menzies, Richard F. Kefford and Georgina V. Long

    Article first published online : 19 JUL 2013, DOI: 10.1111/pcmr.12132